These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 28704113)
1. Role of resveratrol in the management of insulin resistance and related conditions: Mechanism of action. Abbasi Oshaghi E; Goodarzi MT; Higgins V; Adeli K Crit Rev Clin Lab Sci; 2017 Jun; 54(4):267-293. PubMed ID: 28704113 [TBL] [Abstract][Full Text] [Related]
2. Anti-diabetic effects of resveratrol. Szkudelski T; Szkudelska K Ann N Y Acad Sci; 2011 Jan; 1215():34-9. PubMed ID: 21261639 [TBL] [Abstract][Full Text] [Related]
3. Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. Brasnyó P; Molnár GA; Mohás M; Markó L; Laczy B; Cseh J; Mikolás E; Szijártó IA; Mérei A; Halmai R; Mészáros LG; Sümegi B; Wittmann I Br J Nutr; 2011 Aug; 106(3):383-9. PubMed ID: 21385509 [TBL] [Abstract][Full Text] [Related]
4. Effects of compound K on hyperglycemia and insulin resistance in rats with type 2 diabetes mellitus. Jiang S; Ren D; Li J; Yuan G; Li H; Xu G; Han X; Du P; An L Fitoterapia; 2014 Jun; 95():58-64. PubMed ID: 24613802 [TBL] [Abstract][Full Text] [Related]
6. Resveratrol and diabetes: from animal to human studies. Szkudelski T; Szkudelska K Biochim Biophys Acta; 2015 Jun; 1852(6):1145-54. PubMed ID: 25445538 [TBL] [Abstract][Full Text] [Related]
7. Rhizoma Anemarrhenae extract ameliorates hyperglycemia and insulin resistance via activation of AMP-activated protein kinase in diabetic rodents. Han J; Yang N; Zhang F; Zhang C; Liang F; Xie W; Chen W J Ethnopharmacol; 2015 Aug; 172():368-76. PubMed ID: 26162543 [TBL] [Abstract][Full Text] [Related]
8. The antidiabetic action of camel milk in experimental type 2 diabetes mellitus: an overview on the changes in incretin hormones, insulin resistance, and inflammatory cytokines. Korish AA Horm Metab Res; 2014 Jun; 46(6):404-11. PubMed ID: 24627103 [TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory properties of resveratrol in the retinas of type 2 diabetic rats. Ghadiri Soufi F; Arbabi-Aval E; Rezaei Kanavi M; Ahmadieh H Clin Exp Pharmacol Physiol; 2015 Jan; 42(1):63-8. PubMed ID: 25371281 [TBL] [Abstract][Full Text] [Related]
10. Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes. Sullivan TJ; Miao Z; Zhao BN; Ertl LS; Wang Y; Krasinski A; Walters MJ; Powers JP; Dairaghi DJ; Baumgart T; Seitz LC; Berahovich RD; Schall TJ; Jaen JC Metabolism; 2013 Nov; 62(11):1623-32. PubMed ID: 23953944 [TBL] [Abstract][Full Text] [Related]
11. Resveratrol treatment restores peripheral insulin sensitivity in diabetic mice in a sirt1-independent manner. González-Rodríguez Á; Santamaría B; Mas-Gutierrez JA; Rada P; Fernández-Millán E; Pardo V; Álvarez C; Cuadrado A; Ros M; Serrano M; Valverde ÁM Mol Nutr Food Res; 2015 Aug; 59(8):1431-42. PubMed ID: 25808216 [TBL] [Abstract][Full Text] [Related]
12. The role of resveratrol in diabetes and obesity associated with insulin resistance. Hoca M; Becer E; Vatansever HS Arch Physiol Biochem; 2023 Apr; 129(2):555-561. PubMed ID: 33719825 [TBL] [Abstract][Full Text] [Related]
13. Ameliorative potential of resveratrol on proinflammatory cytokines, hyperglycemia mediated oxidative stress, and pancreatic beta-cell dysfunction in streptozotocin-nicotinamide-induced diabetic rats. Palsamy P; Subramanian S J Cell Physiol; 2010 Aug; 224(2):423-32. PubMed ID: 20333650 [TBL] [Abstract][Full Text] [Related]
15. Selenite exacerbates hepatic insulin resistance in mouse model of type 2 diabetes through oxidative stress-mediated JNK pathway. Zhou J; Xu G; Bai Z; Li K; Yan J; Li F; Ma S; Xu H; Huang K Toxicol Appl Pharmacol; 2015 Dec; 289(3):409-18. PubMed ID: 26522834 [TBL] [Abstract][Full Text] [Related]
16. Resveratrol relieves gestational diabetes mellitus in mice through activating AMPK. Yao L; Wan J; Li H; Ding J; Wang Y; Wang X; Li M Reprod Biol Endocrinol; 2015 Nov; 13():118. PubMed ID: 26542478 [TBL] [Abstract][Full Text] [Related]
17. Reduction of oxidative stress by a new low-molecular-weight antioxidant improves metabolic alterations in a nonobese mouse diabetes model. Novelli M; D'Aleo V; Lupi R; Paolini M; Soleti A; Marchetti P; Masiello P Pancreas; 2007 Nov; 35(4):e10-7. PubMed ID: 18090226 [TBL] [Abstract][Full Text] [Related]
18. Metabolic effects of resveratrol: addressing the controversies. Bitterman JL; Chung JH Cell Mol Life Sci; 2015 Apr; 72(8):1473-88. PubMed ID: 25548801 [TBL] [Abstract][Full Text] [Related]
19. Resveratrol and diabetes: A critical review of clinical studies. Öztürk E; Arslan AKK; Yerer MB; Bishayee A Biomed Pharmacother; 2017 Nov; 95():230-234. PubMed ID: 28843911 [TBL] [Abstract][Full Text] [Related]
20. Pterostilbene ameliorates insulin sensitivity, glycemic control and oxidative stress in fructose-fed diabetic rats. Kosuru R; Singh S Life Sci; 2017 Aug; 182():112-121. PubMed ID: 28629731 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]